Literature DB >> 21977153

Reactions of the immune system in epilepsy.

Inimioara Mihaela Cojocaru1, Manole Cojocaru.   

Abstract

Epilepsy may present as a symptom of many neurological disorders and often an etiological explanation cannot be identified. There is growing evidence that autoimmune mechanisms might have a role in some patients. The evidence for immunological mechanisms in epilepsy can be examined within the following three main areas: the childhood epilepsy syndromes, epilepsy associated with other immunologically mediated diseases, and the more common unselected groups of patients with epilepsy. Autoimmunity was recently suspected to be involved in the pathology of certain human epilepsies. This includes numerous reports of the detection of theoretically relevant serum autoantibodies, experimental data showing that antibodies can be epileptogenic, and a response of some epilepsy syndromes to immunomodulation. The high prevalence of epilepsies in specific immune diseases suggests that immune system may play a role in the pathogenesis of epilepsy or might be associated with it. There is some evidence that immune mechanisms play a role in the pathogenesis of some epilepsy syndromes.

Entities:  

Keywords:  autoantibodies; autoimmunity; epilepsy

Year:  2010        PMID: 21977153      PMCID: PMC3177549     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  47 in total

1.  An association between type 1 diabetes and idiopathic generalized epilepsy.

Authors:  Dougall McCorry; A Nicolson; D Smith; A Marson; Richard G Feltbower; D W Chadwick
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

2.  Autoantibodies against glutamate receptor epsilon2-subunit detected in a subgroup of patients with reversible autoimmune limbic encephalitis.

Authors:  A Kimura; T Sakurai; Y Suzuki; Y Hayashi; I Hozumi; O Watanabe; K Arimura; Y Takahashi; T Inuzuka
Journal:  Eur Neurol       Date:  2007-06-29       Impact factor: 1.710

3.  Study of antiphospholipid antibodies in patients treated with antiepileptic drugs.

Authors:  A Pardo; P González-Porque; J M Gobernado; A Jiménez-Escrig; M Lousa
Journal:  Neurologia       Date:  2001-01       Impact factor: 3.109

Review 4.  The use of immunoglobulins in the treatment of human epilepsy.

Authors:  F Villani; G Avanzini
Journal:  Neurol Sci       Date:  2002-04       Impact factor: 3.307

5.  Immune ageing and Alzheimer's disease.

Authors:  M Hartwig
Journal:  Neuroreport       Date:  1995-06-19       Impact factor: 1.837

Review 6.  Acetylcholine receptors and myasthenia.

Authors:  J M Lindstrom
Journal:  Muscle Nerve       Date:  2000-04       Impact factor: 3.217

7.  Glutamate receptor GluR3 antibodies and death of cortical cells.

Authors:  X P He; M Patel; K D Whitney; S Janumpalli; A Tenner; J O McNamara
Journal:  Neuron       Date:  1998-01       Impact factor: 17.173

Review 8.  Landau Kleffner syndrome: electroclinical and etiopathogenic heterogeneity.

Authors:  M B Singh; J Kalita; U K Misra
Journal:  Neurol India       Date:  2002-12       Impact factor: 2.117

Review 9.  Diagnostic and pathogenic significance of glutamate receptor autoantibodies.

Authors:  David Pleasure
Journal:  Arch Neurol       Date:  2008-05

10.  Immunotherapy for epilepsy.

Authors:  Mia Levite; Ian K Hart
Journal:  Expert Rev Neurother       Date:  2002-11       Impact factor: 4.618

View more
  7 in total

1.  Expression Analysis of Vitamin D Signaling Pathway Genes in Epileptic Patients.

Authors:  Mehrdokht Mazdeh; Soudeh Ghafouri-Fard; Mahsa Hatami; Mohammad Mahdi Eftekharian; Maziar Ganji; Arezou Sayad; Shahram Arsang-Jang; Mohammad Taheri; Mir Davood Omrani
Journal:  J Mol Neurosci       Date:  2018-03-16       Impact factor: 3.444

2.  Myoloid-related protein 8, an endogenous ligand of Toll-like receptor 4, is involved in epileptogenesis of mesial temporal lobe epilepsy via activation of the nuclear factor-κB pathway in astrocytes.

Authors:  Na Gan; Lifen Yang; Ahmed Omran; Jing Peng; Liwen Wu; Fang He; Ciliu Zhang; Qiulian Xiang; Huimin Kong; Yupin Ma; Muhammad Usman Ashhab; Xiaolu Deng; Fei Yin
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

3.  Expression Analysis of CYFIP1 and CAMKK2 Genes in the Blood of Epileptic and Schizophrenic Patients.

Authors:  Arezou Sayad; Fatemeh Ranjbaran; Soudeh Ghafouri-Fard; Shahram Arsang-Jang; Mohammad Taheri
Journal:  J Mol Neurosci       Date:  2018-07-11       Impact factor: 3.444

4.  Post Vaccinal Temporary Sensorineural Hearing Loss.

Authors:  Federica De Marco; Donato Pompeo De Cesare; Francesco Di Folco; Francesco Massoni; Gianfranco Tomei; Natale Mario Di Luca; Carmina Sacco; Francesco Tomei; Ricci Serafino
Journal:  Int J Environ Res Public Health       Date:  2018-08-19       Impact factor: 3.390

5.  A 44-year-old patient with a new-onset seizure disorder after vaccination against Japanese encephalitis: a case report.

Authors:  Christoph Schulze
Journal:  J Med Case Rep       Date:  2013-03-12

6.  Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy.

Authors:  Nian Yu; Hao Liu; Qing Di
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

7.  Management of phenytoin-induced gingival enlargement in a patient with antiphospholipid antibody syndrome: A rare case report.

Authors:  Shilpa Sarvesh Urolagin; Deepthi Swaroop; Charu Agrawal; Pathik Dholakia; Menaka Basavanneppa Karalwad
Journal:  J Indian Soc Periodontol       Date:  2016 Sep-Oct
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.